In order to determine whether CTL activity was altered during aging following macrophage depletion and immunotherapy, we next performed in vivo CTL analyses in AE17sOVA tumor-bearing mice ± IL-2/anti-CD40 immunotherapy ± macrophage depletion. This evidence concerns the gene CD40 and neoplasm.